These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28677045)

  • 1. Evaluation of an ADVanced Organ Support (ADVOS) system in a two-hit porcine model of liver failure plus endotoxemia.
    Al-Chalabi A; Matevossian E; von Thaden A; Schreiber C; Radermacher P; Huber W; Perez Ruiz de Garibay A; Kreymann B
    Intensive Care Med Exp; 2017 Dec; 5(1):31. PubMed ID: 28677045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outside of intensive care.
    Kaps L; Ahlbrand CJ; Gadban R; Nagel M; Labenz C; Klimpke P; Holtz S; Boedecker S; Michel M; Kremer WM; Hilscher M; Galle PR; Kraus D; Schattenberg JM; Weinmann-Menke J
    PLoS One; 2021; 16(4):e0249342. PubMed ID: 33793644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Registry on extracorporeal multiple organ support with the advanced organ support (ADVOS) system: 2-year interim analysis.
    Fuhrmann V; Perez Ruiz de Garibay A; Faltlhauser A; Tyczynski B; Jarczak D; Lutz J; Weinmann-Menke J; Kribben A; Kluge S
    Medicine (Baltimore); 2021 Feb; 100(7):e24653. PubMed ID: 33607801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the ADVanced Organ Support (ADVOS) system in critically ill patients with multiple organ failure.
    Acharya M; Berger R; Popov AF
    Artif Organs; 2022 May; 46(5):735-746. PubMed ID: 35128695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced organ support (ADVOS) in the critically ill: first clinical experience in patients with multiple organ failure.
    Fuhrmann V; Weber T; Roedl K; Motaabbed J; Tariparast A; Jarczak D; de Garibay APR; Kluwe J; Boenisch O; Herkner H; Kellum JA; Kluge S
    Ann Intensive Care; 2020 Jul; 10(1):96. PubMed ID: 32676849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First clinical experience in 14 patients treated with ADVOS: a study on feasibility, safety and efficacy of a new type of albumin dialysis.
    Huber W; Henschel B; Schmid R; Al-Chalabi A
    BMC Gastroenterol; 2017 Feb; 17(1):32. PubMed ID: 28209134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of albumin dialysis devices molecular adsorbent recirculating system and ADVanced Organ Support system in critically ill patients with liver failure-A retrospective analysis.
    Falkensteiner C; Kortgen A; Leonhardt J; Bauer M; Sponholz C
    Ther Apher Dial; 2021 Apr; 25(2):225-236. PubMed ID: 32515160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal carbon dioxide removal with the Advanced Organ Support system in critically ill COVID-19 patients.
    Allescher J; Rasch S; Wiessner JR; Perez Ruiz de Garibay A; Huberle C; Hesse F; Schulz D; Schmid RM; Huber W; Lahmer T
    Artif Organs; 2021 Dec; 45(12):1522-1532. PubMed ID: 34309036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Advanced Organ Support (ADVOS) on Cytokine Levels in Patients with Acute-on-Chronic Liver Failure (ACLF).
    Kaps L; Schleicher EM; Medina Montano C; Bros M; Gairing SJ; Ahlbrand CJ; Michel M; Klimpke P; Kremer WM; Holtz S; Boedecker-Lips SC; Galle PR; Kraus D; Schattenberg JM; Labenz C; Weinmann-Menke J
    J Clin Med; 2022 May; 11(10):. PubMed ID: 35628913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful elimination of bilirubin in critically ill patients with acute liver dysfunction using a cytokine adsorber and albumin dialysis: a pilot study.
    Scharf C; Liebchen U; Paal M; Becker-Pennrich A; Irlbeck M; Zoller M; Schroeder I
    Sci Rep; 2021 May; 11(1):10190. PubMed ID: 33986443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory and metabolic acidosis correction with the ADVanced Organ Support system.
    Perez Ruiz de Garibay A; Kellum JA; Honigschnabel J; Kreymann B
    Intensive Care Med Exp; 2019 Sep; 7(1):56. PubMed ID: 31535309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracorporeal multiorgan support including CO
    Huber W; Lorenz G; Heilmaier M; Böttcher K; Sahm P; Middelhoff M; Ritzer B; Schulz D; Bekka E; Hesse F; Poszler A; Geisler F; Spinner C; Schmid RM; Lahmer T
    Int J Artif Organs; 2021 Apr; 44(4):288-294. PubMed ID: 32985328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ADVanced Organ Support (ADVOS) hemodialysis system removes IL-6: an in vitro proof-of-concept study.
    Himmelein S; Perez Ruiz de Garibay A; Brandel V; Zierfuß F; Bingold TM
    Intensive Care Med Exp; 2024 Jul; 12(1):66. PubMed ID: 39083101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Hepa Wash® treatment in pigs with acute liver failure.
    Al-Chalabi A; Matevossian E; V Thaden AK; Luppa P; Neiss A; Schuster T; Yang Z; Schreiber C; Schimmel P; Nairz E; Perren A; Radermacher P; Huber W; Schmid RM; Kreymann B
    BMC Gastroenterol; 2013 May; 13():83. PubMed ID: 23668774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholestatic liver injury increases circulating TNF-alpha and IL-6 and mortality after Escherichia coli endotoxemia.
    Lechner AJ; Velasquez A; Knudsen KR; Johanns CA; Tracy TF; Matuschak GM
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1550-8. PubMed ID: 9603137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of meropenem during advanced organ support (ADVOS
    König C; Kluge S; Fuhrmann V; Jarczak D
    Int J Artif Organs; 2021 Oct; 44(10):783-786. PubMed ID: 34144656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on delay two-phase multiple organ dysfunction syndrome.
    Hu S; Sheng Z; Zhou B; Guo Z; Lu J; Xue L; Jin H; Sun X; Sun S; Li J; Lü Y
    Chin Med J (Engl); 1998 Feb; 111(2):101-8. PubMed ID: 10374366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of gabexate mesilate on coagulopathy and organ dysfunction in rats with endotoxemia: a potential use of thrombelastography in endotoxin-induced sepsis.
    Tsai HJ; Ding C; Tsao CM; Liao MH; Ka SM; Liaw WJ; Wu CC
    Blood Coagul Fibrinolysis; 2015 Mar; 26(2):175-84. PubMed ID: 25396762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ Dysfunction and Failure Following Brain Death Do Not Preclude Successful Donation.
    Essien EI; Parimi N; Gutwald-Miller J; Nutter T; Scalea TM; Stein DM
    World J Surg; 2017 Nov; 41(11):2933-2939. PubMed ID: 28620674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cholestasis markers as predictors of early outcome after liver transplantation.
    Ben-Ari Z; Weiss-Schmilovitz H; Sulkes J; Brown M; Bar-Nathan N; Shaharabani E; Yussim A; Shapira Z; Tur-Kaspa R; Mor E
    Clin Transplant; 2004 Apr; 18(2):130-6. PubMed ID: 15016125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.